company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-444834.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-444834.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6466.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42975.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,182950.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-212443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-212443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-212443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-188076.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-188076.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6467.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,85774.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-32772.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-128607.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-128607.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3440495.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3440495.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3440495.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3311887.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-684443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-684443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13414.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,76569.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,166772.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-427688.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-427688.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-135847.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-135847.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-135847.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-43.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-43.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-43.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-563578.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 14:48:06+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1087637.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1087637.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43612.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,74823.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-217050.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1186252.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1186252.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-613284.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-613284.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-613284.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7875.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7875.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7875.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1791661.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,800.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-702288.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-702288.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46996.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,69931.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5084.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-590445.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-590445.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61478.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61478.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61478.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-651923.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-762123.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-762123.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,55197.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,76711.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,91225.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-538990.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-538990.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-241128.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-241128.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-241128.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,43.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1970958.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5250.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1976251.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1976251.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1196133.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-906126.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-906126.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62496.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,101168.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-55119.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-797581.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-797581.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-225491.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-225491.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-225491.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1023072.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 14:54:56+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-943118.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-943118.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,69433.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,102089.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,100327.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-671269.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-671269.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-85162.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-85162.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-85162.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5934031.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4200.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5938231.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5938231.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5181800.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,800.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1241229.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1241229.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77109.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,86815.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,77912.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-999393.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-999393.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-180443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-180443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-180443.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1179836.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1754527.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1754527.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83962.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,572928.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-231120.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1328757.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1328757.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56904.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-56904.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-56904.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-31.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,31800.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31769.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31769.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1353892.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,200.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2522000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2522000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,253000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-316000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2482000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2482000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-157000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-207000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-207000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,876000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6354000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7237000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7237000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4548000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:10:55+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4737000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4737000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,226000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,193000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,503000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3815000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3815000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-49000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-49000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-49000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3885000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,8000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3356000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3356000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,309000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,211000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-145000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2981000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2981000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-181000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-461000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,126000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-516000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-516000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4173000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4173000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4173000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,676000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,39000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11296000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11296000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,652000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3037000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,396000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7211000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7211000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,302000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,241000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,241000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1850000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,31347000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32207000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32207000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25237000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-48000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10093000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10093000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,774000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2210000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2015000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9124000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9124000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-94000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-94000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1718000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,136000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,2014-01-01,2014-03-31,2014-05-14 16:10:55+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8454000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8454000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,793000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,749000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,524000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6388000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6388000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-104000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-104000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-104000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26698000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26698000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26698000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20206000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,251000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7605000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7605000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,805000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,749000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,455000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5596000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5596000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-235000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-235000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-235000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-55000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-55000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-55000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5886000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,249000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8505000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8505000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,812000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,925000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-888000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-158000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10158000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10158000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45143000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,304000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45447000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45447000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27633000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,908000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10438000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10438000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,823000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1536000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-768000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8847000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8847000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-343000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1843000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1843000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,289000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-711000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-711000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11401000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,248000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 21:43:47+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10958000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10958000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,604000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10149000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1295000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1295000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-157000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10157000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10157000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-758000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,818000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8802000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-248000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2079000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2079000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,410000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-52670000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,35984000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18355000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18355000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1450000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,27759000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26309000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26309000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1157000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,571000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-586000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-586000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7368000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,720000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26599000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26599000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,533000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7130000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2774000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16162000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16162000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1757000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1757000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1757000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1180000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,49000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,21000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2110000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2110000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20029000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,854000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2998000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17287000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17287000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,545000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3488000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,44000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20186000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20186000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-596000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-596000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-596000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1204000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3486000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,275000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2557000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2557000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18225000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,307000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:05:12+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44469000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44469000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,556000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,26156000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5581000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12176000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12176000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1634000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1634000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1634000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1227000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,92265000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,138000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,91176000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,91176000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,77366000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,273000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15743000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15743000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,122000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-58698000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,20783000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22050000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22050000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1458000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-750000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-600000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2808000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2808000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1252000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15639000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9726000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7124000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7124000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31982000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,198000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17924000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17924000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1662000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-334000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16516000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16516000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3172000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10592000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,750000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,600000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12414000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12414000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5768000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48320000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2509000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,70000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45131000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45131000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16201000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,564000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23803000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23803000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1454000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,166000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1980000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1711000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21914000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21914000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4161000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4161000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4161000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1012000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-22482000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-22482000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48557000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:21:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1300000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14739000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14739000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1734000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,205000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-381000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6569000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19750000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19750000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2622000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3557000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6179000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6179000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45598000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45598000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45598000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19669000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,744000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,30000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1452000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1452000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2083000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,84000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-82755000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,66472000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12664000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12664000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2588000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4588000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4588000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2046000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2046000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2046000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15206000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,764000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48199000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48199000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1867000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-455000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16846000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-111309000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44852000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44852000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1601000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1601000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1601000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-31657000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,49916000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10254000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28513000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28513000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17940000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,691000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33548000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33548000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2005000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15027000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7448000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23963000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23963000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-448000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-448000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-448000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-22466000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,21586000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48958000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,155000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28233000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28233000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3822000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:00:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,128000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74807000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74807000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1926000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,514000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,48963000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1282000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22122000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22122000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2364000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2364000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2364000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,37849000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9315000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47171000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47171000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22685000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50454000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50454000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2261000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2119000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11714000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20704000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20704000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2936000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12936000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12936000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,20000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,114275000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13208000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19816000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,167299000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,167299000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,133659000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,325000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53717000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53717000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3302000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2634000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15680000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7609000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44978000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44978000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5447000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,10000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5447000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5447000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,110935000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12127000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-19767000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,83295000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,83295000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32870000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,167000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-9000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-146529000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-146529000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3471000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1292000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,98875000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1418000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44309000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44309000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5228000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-17040000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22268000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22268000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1178000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,81000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1097000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1097000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-67674000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:02:10+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2505000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71845000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71845000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2463000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1998000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20268000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,282000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46834000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46834000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2260000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-17040000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,17040000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2260000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2260000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-480000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18858000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1125000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19503000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19503000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29591000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3673000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,13000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-75212000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-75212000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2314000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1369000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21100000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4598000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45831000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45831000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2094000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,15878000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-17040000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3256000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3256000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-783000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24269000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-917000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22569000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22569000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26518000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3868000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-69426000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-69426000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2741000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-606000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27856000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3413000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36022000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36022000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1860000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8529000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10389000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10389000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-633000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6553000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23428000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8562000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,37910000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,37910000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8501000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2692000.0
